menu
    • menu

    Company profile for ReGenTree

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ReGenTree, LLC is a newly created U.S. joint venture company owned by GtreeBNT Co., Ltd., a bio venture company in Korea and by RegeneRx Biopharmaceuticals, Inc., a clinical stage drug development company in the USA. As of January 2015, ReGenTree is developing a novel therapeutic peptide, RGN-259 (designated GBT-201 in Korea), in the USA for ophthalmic indications. GtreeBNT holds a major equity stake in ReGenTree and is respo...
    ReGenTree, LLC is a newly created U.S. joint venture company owned by GtreeBNT Co., Ltd., a bio venture company in Korea and by RegeneRx Biopharmaceuticals, Inc., a clinical stage drug development company in the USA. As of January 2015, ReGenTree is developing a novel therapeutic peptide, RGN-259 (designated GBT-201 in Korea), in the USA for ophthalmic indications. GtreeBNT holds a major equity stake in ReGenTree and is responsible for conducting and funding all clinical trials and product development. RegeneRx contributes all of its related intellectual property and non-clinical and clinical data generated to date.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ReGenTreeUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    116 Village Blvd Suite 200 Princeton, NJ 08540
    Telephone
    Telephone
    609-734-4328
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://regentreellc.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ReGenTree Announces Additional Results from ARISE-3 and After Pooling Data
    ReGenTree Announces Additional Results from ARISE-3 and After Pooling Data

    14 May 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/regentree-announces-additional-results-from-arise-3-and-after-pooling-data-from-three-phase-3-clinical-trials-using-rgn-259-for-the-treatment-of-dry-eye-301291451.html

    PRNEWSWIRE
    14 May 2021
    Share Share
    ReGenTree Announces Efficacy Results of Ph 3 Clinical Trial RGN-259
    ReGenTree Announces Efficacy Results of Ph 3 Clinical Trial RGN-259

    14 May 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/regentree-announces-efficacy-results-of-the-neurotrophic-keratopathy-phase-3-clinical-trial-with-rgn-259-301059114.html

    PRNEWSWIRE
    14 May 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search